ROBENGATOPE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Robengatope, and when can generic versions of Robengatope launch?
Robengatope is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in ROBENGATOPE is rose bengal sodium i-131. There are one hundred and four drug master file entries for this compound. Additional details are available on the rose bengal sodium i-131 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROBENGATOPE?
- What are the global sales for ROBENGATOPE?
- What is Average Wholesale Price for ROBENGATOPE?
Summary for ROBENGATOPE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ROBENGATOPE at DailyMed |
US Patents and Regulatory Information for ROBENGATOPE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | ROBENGATOPE | rose bengal sodium i-131 | INJECTABLE;INJECTION | 016224-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bracco | ROBENGATOPE | rose bengal sodium i-131 | INJECTABLE;INJECTION | 016224-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bracco | ROBENGATOPE | rose bengal sodium i-131 | INJECTABLE;INJECTION | 016224-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
